Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

June M Chan

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Carcinogenesis|August 31, 2018
Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal diseaseThomas U Ahearn, Sam Peisch, Andreas Pettersson, et al.
Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
The Journal of Urology|September 10, 2021
Reply by AuthorsLauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
The Journal of Urology|September 10, 2021
Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional CohortLauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
Carcinogenesis|April 2, 2005
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer typesAmanda Ewart-Toland, Qi Dai, Yu-Tang Gao, et al.
Advances in Anatomic Pathology|December 13, 2012
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue MicroarraySarah Hawley, Ladan Fazli, Jesse K McKenney, et al.
Annals of Internal Medicine|October 8, 2008
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studiesAndrew W Roddam, Naomi E Allen, Paul Appleby, et al.
European Urology|August 6, 2018
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective StudiesEleanor L Watts, Paul N Appleby, Aurora Perez-Cornago, et al.
Human Genetics|February 27, 2015
Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 casesBrian T Helfand, Kimberly A Roehl, Phillip R Cooper, et al.
Cancer Research|February 28, 2016
A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer RiskRuth C Travis, Paul N Appleby, Richard M Martin, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Carcinogenesis|August 31, 2018
Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal diseaseThomas U Ahearn, Sam Peisch, Andreas Pettersson, et al.
Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
The Journal of Urology|September 10, 2021
Reply by AuthorsLauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
The Journal of Urology|September 10, 2021
Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional CohortLauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
Carcinogenesis|April 2, 2005
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer typesAmanda Ewart-Toland, Qi Dai, Yu-Tang Gao, et al.
Advances in Anatomic Pathology|December 13, 2012
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue MicroarraySarah Hawley, Ladan Fazli, Jesse K McKenney, et al.
Annals of Internal Medicine|October 8, 2008
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studiesAndrew W Roddam, Naomi E Allen, Paul Appleby, et al.
European Urology|August 6, 2018
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective StudiesEleanor L Watts, Paul N Appleby, Aurora Perez-Cornago, et al.
Human Genetics|February 27, 2015
Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 casesBrian T Helfand, Kimberly A Roehl, Phillip R Cooper, et al.
Cancer Research|February 28, 2016
A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer RiskRuth C Travis, Paul N Appleby, Richard M Martin, et al.
Pageof 18